ARWR logo

ARWR CAPEX

Annual CAPEX

$141.47 M
-$35.27 M-19.96%

September 30, 2024

Summary

Performance

1-Year Change

-19.96%

3-Year Change

+500.28%

5-Year Change

+1078.81%

15-Year Change

+1686.63%

ARWR CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.08%
ARWR annual capital expenditures is higher than 89.08% of companies in Healthcare sector

High & Low

All-time High

$176.74 M
ARWR annual capital expenditures is currently -19.96% below its historical high of $176.74 million

3-Year Low

$23.57 M
ARWR annual capital expenditures is currently +500.28% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
ARWR previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
ARWR next annual earnings announcement has not yet been scheduled

OtherARWRcash flowmetrics:

Annual FCF

-$604.32 M
ARWR annual free cash flow is -$604.32 million

Annual CFO

-$462.85 M
ARWR annual cash flow from operations is -$462.85 million

Annual CFI

-$420.07 M
ARWR annual cash flow from investing activities is -$420.07 million

Annual CFF

$870.52 M
ARWR annual cash flow from financing activities is $870.52 million

Quarterly CAPEX

$7.52 M
-$16.77 M-69.06%

December 31, 2024

Summary

Performance

3-Month Change

-69.06%

1-Year Change

-69.06%

3-Year Change

-69.06%

5-Year Change

-69.06%

ARWR Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.56%
ARWR quarterly capital expenditures is higher than 77.56% of companies in Healthcare sector

High & Low

All-time High

$68.66 M
ARWR quarterly capital expenditures is currently -89.05% below its historical high of $68.66 million

3-Year Low

$4.75 M
ARWR quarterly capital expenditures is currently +58.16% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ARWR previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ARWR next earnings announcement is scheduled for May 9, 2025

OtherARWRcash flowmetrics:

Quarterly FCF

-$153.79 M
ARWR quarterly free cash flow is -$153.79 million

Quarterly CFO

-$146.27 M
ARWR quarterly cash flow from operations is -$146.27 million

Quarterly CFI

$76.91 M
ARWR quarterly cash flow from investing activities is $76.91 million

Quarterly CFF

$20.63 M
ARWR quarterly cash flow from financing activities is $20.63 million

TTM CAPEX

$80.33 M
-$61.14 M-43.22%

December 31, 2024

Summary

Performance

3-Month Change

-43.22%

1-Year Change

-43.22%

3-Year Change

-43.22%

5-Year Change

-43.22%

ARWR TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.24%
ARWR TTM capital expenditures is higher than 85.24% of companies in Healthcare sector

High & Low

All-time High

$213.24 M
ARWR TTM capital expenditures is currently -62.33% below its historical high of $213.24 million

3-Year Low

$22.66 M
ARWR TTM capital expenditures is currently +254.50% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ARWR previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ARWR next earnings announcement is scheduled for May 9, 2025

OtherARWRcash flowmetrics:

TTM FCF

-$571.61 M
ARWR TTM free cash flow is -$571.61 million

TTM CFO

-$491.28 M
ARWR TTM cash flow from operations is -$491.28 million

TTM CFI

-$408.00 M
ARWR TTM cash flow from investing activities is -$408.00 million

TTM CFF

$890.89 M
ARWR TTM cash flow from financing activities is $890.89 million

ARWR CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-20.0%-69.1%-43.2%
3 y3 years+500.3%-69.1%-43.2%
5 y5 years+1078.8%-69.1%-43.2%

ARWR CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-20.0%+500.3%-89.0%+58.2%-62.3%+254.5%
5 y5-year-20.0%+1083.6%-89.0%+298.7%-62.3%+574.9%
alltimeall time-20.0%>+9999.0%-89.0%>+9999.0%-62.3%>+9999.0%

Arrowhead Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
-
$7.52 M(-69.1%)
$80.33 M(-43.2%)
Sep 2024
$141.47 M(-20.0%)
$24.29 M(+68.1%)
$141.47 M(-21.9%)
Jun 2024
-
$14.45 M(-57.6%)
$181.09 M(-15.1%)
Mar 2024
-
$34.08 M(-50.4%)
$213.24 M(+3.3%)
Dec 2023
-
$68.66 M(+7.4%)
$206.48 M(+16.8%)
Sep 2023
$176.74 M(+234.9%)
$63.91 M(+37.1%)
$176.74 M(+21.4%)
Jun 2023
-
$46.60 M(+70.6%)
$145.54 M(+34.2%)
Mar 2023
-
$27.31 M(-29.8%)
$108.47 M(+26.3%)
Dec 2022
-
$38.91 M(+19.0%)
$85.91 M(+62.8%)
Sep 2022
$52.78 M(+123.9%)
$32.71 M(+243.0%)
$52.78 M(+86.7%)
Jun 2022
-
$9.54 M(+100.7%)
$28.27 M(+24.7%)
Mar 2022
-
$4.75 M(-17.8%)
$22.66 M(-9.6%)
Dec 2021
-
$5.78 M(-29.5%)
$25.07 M(+6.4%)
Sep 2021
$23.57 M(+97.2%)
$8.20 M(+108.6%)
$23.57 M(+36.6%)
Jun 2021
-
$3.93 M(-45.1%)
$17.25 M(+11.6%)
Mar 2021
-
$7.17 M(+67.8%)
$15.46 M(+29.9%)
Dec 2020
-
$4.27 M(+126.6%)
$11.90 M(-0.4%)
Sep 2020
$11.95 M(-0.4%)
$1.89 M(-11.8%)
$11.95 M(-33.2%)
Jun 2020
-
$2.14 M(-40.8%)
$17.90 M(-5.7%)
Mar 2020
-
$3.61 M(-16.5%)
$18.98 M(+21.8%)
Dec 2019
-
$4.32 M(-44.8%)
$15.58 M(+29.9%)
Sep 2019
$12.00 M(+744.4%)
$7.83 M(+142.9%)
$12.00 M(+145.9%)
Jun 2019
-
$3.22 M(+1440.1%)
$4.88 M(+163.1%)
Mar 2019
-
$209.30 K(-71.6%)
$1.85 M(-8.4%)
Dec 2018
-
$737.50 K(+3.9%)
$2.02 M(+42.4%)
Sep 2018
$1.42 M(-82.1%)
$709.50 K(+258.2%)
$1.42 M(+73.5%)
Jun 2018
-
$198.10 K(-47.6%)
$819.20 K(-53.9%)
Mar 2018
-
$378.30 K(+179.4%)
$1.78 M(-35.5%)
Dec 2017
-
$135.40 K(+26.1%)
$2.76 M(-65.2%)
Sep 2017
$7.92 M(+105.1%)
$107.40 K(-90.7%)
$7.92 M(-24.8%)
Jun 2017
-
$1.16 M(-14.7%)
$10.52 M(+5.1%)
Mar 2017
-
$1.36 M(-74.4%)
$10.01 M(+14.4%)
Dec 2016
-
$5.30 M(+95.3%)
$8.75 M(+126.7%)
Sep 2016
$3.86 M(+95.9%)
$2.71 M(+319.2%)
$3.86 M(+94.7%)
Jun 2016
-
$647.10 K(+588.4%)
$1.98 M(+22.4%)
Mar 2016
-
$94.00 K(-76.9%)
$1.62 M(-11.1%)
Dec 2015
-
$406.60 K(-51.3%)
$1.82 M(-7.5%)
Sep 2015
$1.97 M(+14.7%)
$835.00 K(+194.4%)
$1.97 M(+23.1%)
Jun 2015
-
$283.60 K(-4.5%)
$1.60 M(-18.4%)
Mar 2015
-
$297.10 K(-46.5%)
$1.96 M(-9.0%)
Dec 2014
-
$554.90 K(+19.2%)
$2.16 M(+25.5%)
Sep 2014
$1.72 M
$465.40 K(-27.8%)
$1.72 M(+26.5%)
Jun 2014
-
$644.20 K(+31.0%)
$1.36 M(+55.4%)
DateAnnualQuarterlyTTM
Mar 2014
-
$491.60 K(+323.1%)
$873.20 K(+116.4%)
Dec 2013
-
$116.20 K(+10.5%)
$403.60 K(+36.0%)
Sep 2013
$296.90 K(-38.1%)
$105.20 K(-34.3%)
$296.80 K(+6.6%)
Jun 2013
-
$160.20 K(+628.2%)
$278.50 K(+19.1%)
Mar 2013
-
$22.00 K(+134.0%)
$233.90 K(-44.3%)
Dec 2012
-
$9400.00(-89.2%)
$419.70 K(-12.5%)
Sep 2012
$479.70 K(+4845.4%)
$86.90 K(-24.8%)
$479.70 K(+22.1%)
Jun 2012
-
$115.60 K(-44.4%)
$392.80 K(+39.8%)
Mar 2012
-
$207.80 K(+199.4%)
$281.00 K(+255.2%)
Dec 2011
-
$69.40 K(>+9900.0%)
$79.10 K(+715.5%)
Sep 2011
$9700.00(-75.9%)
$0.00(-100.0%)
$9700.00(0.0%)
Jun 2011
-
$3800.00(-35.6%)
$9700.00(+64.4%)
Mar 2011
-
$5900.00(>+9900.0%)
$5900.00(-85.3%)
Sep 2009
$40.20 K(-94.1%)
$0.00(-100.0%)
$40.20 K(-81.3%)
Jun 2009
-
$12.10 K(>+9900.0%)
$215.40 K(-39.6%)
Mar 2009
-
$0.00(-100.0%)
$356.60 K(-34.5%)
Dec 2008
-
$28.10 K(-84.0%)
$544.50 K(-20.4%)
Sep 2008
$684.10 K(-9.6%)
$175.20 K(+14.3%)
$684.20 K(-2.5%)
Jun 2008
-
$153.30 K(-18.4%)
$701.70 K(-26.8%)
Mar 2008
-
$187.90 K(+12.0%)
$959.00 K(+18.6%)
Dec 2007
-
$167.80 K(-12.9%)
$808.70 K(+6.9%)
Sep 2007
$756.40 K(-19.1%)
$192.70 K(-53.1%)
$756.50 K(-13.2%)
Jun 2007
-
$410.60 K(+992.0%)
$871.60 K(+12.8%)
Mar 2007
-
$37.60 K(-67.5%)
$772.60 K(-19.0%)
Dec 2006
-
$115.60 K(-62.4%)
$953.50 K(+2.0%)
Sep 2006
$934.50 K(+38.9%)
$307.80 K(-1.2%)
$934.50 K(+58.4%)
Jun 2006
-
$311.60 K(+42.6%)
$590.00 K(+14.2%)
Mar 2006
-
$218.50 K(+126.2%)
$516.80 K(+32.1%)
Dec 2005
-
$96.60 K(-363.2%)
$391.10 K(-41.9%)
Sep 2005
$672.80 K(+1.1%)
-$36.70 K(-115.4%)
$672.70 K(-41.7%)
Jun 2005
-
$238.40 K(+156.9%)
$1.15 M(+2.2%)
Mar 2005
-
$92.80 K(-75.5%)
$1.13 M(+8.1%)
Dec 2004
-
$378.20 K(-14.8%)
$1.04 M(+56.8%)
Sep 2004
$665.50 K(>+9900.0%)
$443.90 K(+107.9%)
$665.50 K(+200.3%)
Jun 2004
-
$213.50 K(+2535.8%)
$221.60 K(+2635.8%)
Mar 2004
-
$8100.00(>+9900.0%)
$8100.00(+376.5%)
Sep 2003
$2100.00(+23.5%)
-
-
Sep 2002
$1700.00(+142.9%)
$0.00(0.0%)
$1700.00(0.0%)
Jun 2002
-
$0.00(-100.0%)
$1700.00(0.0%)
Mar 2002
-
$1700.00(>+9900.0%)
$1700.00(+142.9%)
Sep 2000
$700.00
$0.00(0.0%)
$700.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$700.00(0.0%)
Mar 2000
-
$0.00(-100.0%)
$700.00(0.0%)
Dec 1999
-
$700.00
$700.00

FAQ

  • What is Arrowhead Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals annual CAPEX year-on-year change?
  • What is Arrowhead Pharmaceuticals quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals quarterly CAPEX year-on-year change?
  • What is Arrowhead Pharmaceuticals TTM capital expenditures?
  • What is the all time high TTM CAPEX for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals TTM CAPEX year-on-year change?

What is Arrowhead Pharmaceuticals annual capital expenditures?

The current annual CAPEX of ARWR is $141.47 M

What is the all time high annual CAPEX for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high annual capital expenditures is $176.74 M

What is Arrowhead Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, ARWR annual capital expenditures has changed by -$35.27 M (-19.96%)

What is Arrowhead Pharmaceuticals quarterly capital expenditures?

The current quarterly CAPEX of ARWR is $7.52 M

What is the all time high quarterly CAPEX for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high quarterly capital expenditures is $68.66 M

What is Arrowhead Pharmaceuticals quarterly CAPEX year-on-year change?

Over the past year, ARWR quarterly capital expenditures has changed by -$16.77 M (-69.06%)

What is Arrowhead Pharmaceuticals TTM capital expenditures?

The current TTM CAPEX of ARWR is $80.33 M

What is the all time high TTM CAPEX for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high TTM capital expenditures is $213.24 M

What is Arrowhead Pharmaceuticals TTM CAPEX year-on-year change?

Over the past year, ARWR TTM capital expenditures has changed by -$61.14 M (-43.22%)